Prognostic significance of CDC20 expression in malignancy patients: A meta-analysis
BackgroundCell Division Cycle Protein 20(CDC20) is reported to promote cancer initiation, progression and drug resistance in many preclinical models and is demonstrated in human cancer tissues. However, the correlation between CDC20 and cancer patients’ prognosis has not yet been systematically eval...
Main Authors: | Feng Xian, Xuegang Yang, Guohui Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1017864/full |
Similar Items
-
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
by: Samantha Bruno, et al.
Published: (2022-04-01) -
Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression
by: Chang David Z, et al.
Published: (2012-04-01) -
Pretreatment thrombocytosis as a significant prognostic factor in malignant mesothelioma: a meta-analysis
by: Yi Zhuo, et al.
Published: (2017-08-01) -
Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis
by: Shengjie Sun, et al.
Published: (2020-06-01) -
The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors
by: Fei Wu, et al.
Published: (2021-08-01)